Thomas F. Tedder, PhD - Duke Medicine

Leadership Chancellor Administration Victor J. Dzau, MD R. Sanders Williams, MD Nancy Andrews, MD, PhD Catherine Lynch Gilliss, DNSc Asif Ahmad Monte D. Brown, MD Robert M. Califf, MD Michael Cuffe, MD Karen Frush, MD Mary Ann Fuchs, RN William J. Fulkerson Jr., MD Ranga R. Krishnan, MB ChB Kenneth C. Morris Michael J. Morsberger Paul Newman Molly O'Neill Robert L. Taber, PhD Douglas B. Vinsel Kerry Watson Huntington F. Willard, PhD Mark Newman, MD Kenneth Kreuzer, PhD Elizabeth DeLong, PhD Brigid Hogan, PhD J. Lloyd Michener, MD Thomas F. Tedder, PhD Harvey Jay Cohen, MD Thomas Petes, PhD James McNamara, MD Haywood Brown, MD David L. Epstein, MD Salvatore Pizzo, MD, PhD Joseph St. Geme III, MD Anthony R. Means, PhD Ranga R. Krishnan, MB ChB Christopher Willett, MD Carl E. Ravin, MD Danny O. Jacobs, MD Board Members
	Home > Leadership > Administration > Thomas F. Tedder, PhD Thomas F. Tedder, PhD Thomas Tedder, PhD, is the Alter Geller Professor for Research in Immunology and chair of the Department of Immunology at Duke University Medical Center. He also serves as director of the Duke Automated DNA Sequence Analysis Facility. Tedder received his undergraduate and master's degrees from the University of Florida and a PhD degree in molecular cell biology from the University of Alabama at Birmingham. Upon graduating in 1984, Tedder became a research fellow in pathology at Harvard Medical School. In 1985 he joined the faculty at Harvard, first as an instructor, then as assistant professor of pathology. He was also a principal investigator in the Division of Tumor Immunology at the Dana-Farber Cancer Institute in Boston during that time. He joined Duke as professor and chair of the Duke Department of Immunology in 1993. Tedder’s research stems from a deep interest in cancer biology, immunodeficiency syndromes, and autoimmune diseases. He was one of the first scientists to identify and characterize multiple surface molecules important for leukocyte function. His current work focuses on the identification, structural characterization, and functional analysis of cell surface molecules that regulate B lymphocyte development and function. A scholar with the Leukemia Society of America from 1991 to 1996, the Leukemia Society presented him with its highest award for research in the field of hematology/oncology in 1995. Tedder has published more than 320 scholarly papers in leading scientific publications.